Takeda Pharmaceutical Company Ltd
- Country
- π―π΅Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
Agrylin Drug Use-Result Survey
- Conditions
- Essential Thrombocythemia (ET)
- First Posted Date
- 2018-08-10
- Last Posted Date
- 2023-02-27
- Lead Sponsor
- Takeda
- Target Recruit Count
- 1826
- Registration Number
- NCT03625895
- Locations
- π―π΅
Nerima-ku, Nerima-ku, Tokyo, Japan
π―π΅Bunkyo-ku, Bunkyo-ku, Tokyo, Japan
π―π΅Koganei-city, Koganei-city, Tokyo, Japan
Survey Study for Velaglucerase Alfa (VPRIV) in Japan
- Conditions
- Gaucher Disease
- First Posted Date
- 2018-08-10
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Takeda
- Target Recruit Count
- 63
- Registration Number
- NCT03625882
- Locations
- π―π΅
Nagoya, Nagoya, Aichi, Japan
π―π΅Higashihiroshima, Higashihiroshima, Hiroshima, Japan
π―π΅Fukuyama, Fukuyama, Hiroshima, Japan
A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2020-01-14
- Lead Sponsor
- Takeda
- Registration Number
- NCT03608501
- Locations
- π§π·
Instituto COI de Educacao e Pesquisa, Rio de Janeiro, RJ, Brazil
π§π·Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil
π§π·Universidade Estadual de Campinas UNICAMP - HEMOCENTRO, Campinas, SP, Brazil
A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer
- First Posted Date
- 2018-07-24
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Takeda
- Target Recruit Count
- 248
- Registration Number
- NCT03596866
- Locations
- π¦π·
Sanatorio Duarte Quiros, Cordoba, Argentina
π¨π³Peking Union Medical College Hospital - East, Beijing, Beijing, China
π¨π±Centro de Investigacion Clinica Bradford Hill, Recoleta, Santiago, Chile
An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004
- Conditions
- Short Bowel Syndrome
- Interventions
- First Posted Date
- 2018-07-23
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Takeda
- Target Recruit Count
- 11
- Registration Number
- NCT03596164
- Locations
- π―π΅
Tohoku University Hospital, Miyagi-Ken, Japan
π―π΅Osaka University Hospital, Osaka, Japan
π―π΅Hyogo College of Medicine Hospital, Hyogo, Japan
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
- Conditions
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
- Interventions
- First Posted Date
- 2018-07-17
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Takeda
- Target Recruit Count
- 245
- Registration Number
- NCT03589326
- Locations
- πΊπΈ
Augusta University Georgia Cancer Center, Augusta, Georgia, United States
π¨π¦Hopital Charles-LeMoyne, Greenfield Park, Quebec, Canada
π§π¬University Multiprofile Hospital for Active Treatment Saint Ivan Rilski, Sofia, Sofiya, Bulgaria
A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma
- First Posted Date
- 2018-07-16
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Takeda
- Target Recruit Count
- 34
- Registration Number
- NCT03586973
- Locations
- π―π΅
Hiroshima University Hospital, Hiroshima, Japan
π―π΅Okayama University Hospital, Okayama, Japan
π―π΅Yokohama City University Medical Center, Yokohama, Kanagawa, Japan
Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2018-06-13
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Takeda
- Target Recruit Count
- 1026
- Registration Number
- NCT03555565
- Locations
- π―π΅
Takeda Selected Site, Tokyo, Japan
Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus"
- First Posted Date
- 2018-06-13
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- Takeda
- Target Recruit Count
- 3198
- Registration Number
- NCT03555591
- Locations
- π―π΅
Takeda Selected Site, Tokyo, Japan
Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"
- First Posted Date
- 2018-06-13
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Takeda
- Target Recruit Count
- 300
- Registration Number
- NCT03555578
- Locations
- π―π΅
Takeda Selected Site, Tokyo, Japan